Literature DB >> 23054371

A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.

Hilary A Seifert1, Aaron A Hall, Cortney B Chapman, Lisa A Collier, Alison E Willing, Keith R Pennypacker.   

Abstract

The splenic response to stroke is a proinflammatory reaction to ischemic injury resulting in expanded neurodegeneration. Splenectomy reduces neural injury in rodent models of hemorrhagic and ischemic stroke, however the exact nature of this response has yet to be fully understood. This study examines the migration of splenocytes after brain ischemia utilizing carboxyfluorescein diacetate succinimidyl ester (CFSE) to label them in vivo. The spleen was found to significantly decrease in size from 24 to 48 h following middle cerebral artery occlusion (MCAO) in rats compared to sham operated controls. By 96 h post-MCAO the spleen size returned to levels not different from sham operated rats. To track splenocyte migration following MCAO, spleens were injected with CFSE to label cells. CFSE positive cell numbers were significantly reduced in the 48 h MCAO group versus 48 h sham and CFSE labeled cells were equivalent in 96 h MCAO and sham groups. A significant increase of labeled lymphocyte, monocytes, and neutrophils was detected in the blood at 48 h post-MCAO when compared to the other groups. CFSE labeled cells migrated to the brain following MCAO but appear to remain within the vasculature. These cells were identified as natural killer cells (NK) and monocytes at 48 h and at 96 h post-MCAO NK cells, T cells and monocytes. After ischemic injury, splenocytes enter into systemic circulation and migrate to the brain exacerbating neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054371      PMCID: PMC3518577          DOI: 10.1007/s11481-012-9406-8

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  37 in total

1.  Fluorescein labeling of murine hepatocytes for identification after intrahepatic transplantation.

Authors:  F M Karrer; B L Reitz; L Hao; K J Lafferty
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy.

Authors:  S A Weston; C R Parish
Journal:  J Immunol Methods       Date:  1990-10-04       Impact factor: 2.303

3.  Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats.

Authors:  Alain Gendron; Jeanne Teitelbaum; Chantal Cossette; Stephen Nuara; Marc Dumont; David Geadah; Patrick du Souich; Edouard Kouassi
Journal:  Brain Res       Date:  2002-11-15       Impact factor: 3.252

4.  The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice.

Authors:  Susan L Stevens; Jianzhong Bao; Jacob Hollis; Nikola S Lessov; Wayne M Clark; Mary P Stenzel-Poore
Journal:  Brain Res       Date:  2002-04-05       Impact factor: 3.252

5.  The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.

Authors:  S I Savitz; J A Erhardt; J V Anthony; G Gupta; X Li; F C Barone; D M Rosenbaum
Journal:  J Cereb Blood Flow Metab       Date:  2000-08       Impact factor: 6.200

6.  The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling.

Authors:  Hilary A Seifert; Christopher C Leonardo; Aaron A Hall; Derrick D Rowe; Lisa A Collier; Stanley A Benkovic; Alison E Willing; Keith R Pennypacker
Journal:  Metab Brain Dis       Date:  2012-02-22       Impact factor: 3.584

7.  Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model.

Authors:  Yukihide Kanemoto; Hiroyuki Nakase; Nobuhisa Akita; Toshisuke Sakaki
Journal:  Neurosurgery       Date:  2002-10       Impact factor: 4.654

8.  Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex.

Authors:  S Meyer; M Strittmatter; C Fischer; T Georg; B Schmitz
Journal:  Neuroreport       Date:  2004-02-09       Impact factor: 1.837

9.  Splenectomy attenuates intestinal ischemia-reperfusion-induced acute lung injury.

Authors:  M Cagri Savas; Meltem Ozguner; I Faruk Ozguner; Namik Delibas
Journal:  J Pediatr Surg       Date:  2003-10       Impact factor: 2.545

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  80 in total

1.  Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage.

Authors:  Farhaan S Vahidy; Kaushik N Parsha; Mohammad H Rahbar; MinJae Lee; Thanh-Tung Bui; Claude Nguyen; Andrew D Barreto; Arvind B Bambhroliya; Preeti Sahota; Bing Yang; Jaroslaw Aronowski; Sean I Savitz
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

Review 2.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

3.  Splenectomy Does Not Improve Long-Term Outcome After Stroke.

Authors:  Dannielle Zierath; Angela Shen; Astiana Stults; Theresa Olmstead; Kyra J Becker
Journal:  Stroke       Date:  2017-01-13       Impact factor: 7.914

4.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

Review 5.  Regulatory B cells in experimental stroke.

Authors:  Hilary A Seifert; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2018-02-05       Impact factor: 7.397

6.  A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.

Authors:  Gil Benedek; Wenbin Zhu; Nicole Libal; Amanda Casper; Xiaolin Yu; Roberto Meza-Romero; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-03       Impact factor: 3.584

Review 7.  Inflammation and Stroke: An Overview.

Authors:  Josef Anrather; Costantino Iadecola
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

8.  Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain.

Authors:  Eric S Wohleb; Daniel B McKim; Daniel T Shea; Nicole D Powell; Andrew J Tarr; John F Sheridan; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-12-10       Impact factor: 13.382

9.  Sympathetic Release of Splenic Monocytes Promotes Recurring Anxiety Following Repeated Social Defeat.

Authors:  Daniel B McKim; Jenna M Patterson; Eric S Wohleb; Brant L Jarrett; Brenda F Reader; Jonathan P Godbout; John F Sheridan
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

Review 10.  The innate immune system after ischemic injury: lessons to be learned from the heart and brain.

Authors:  Gabriel Courties; Michael A Moskowitz; Matthias Nahrendorf
Journal:  JAMA Neurol       Date:  2014-02       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.